Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Comparison of the long-term efficacy between entecavir and tenofovir in treatment- naïve chronic hepatitis B patients

Fig. 1

Change of HBV DNA during follow-up period. a The changes in the mean hepatitis B virus (HBV) DNA levels from baseline through week 48. The overall mean changes at weeks 12, 24 and 48 were −4.26 log10 IU/mL, −4.89 log10 IU/mL and −5.12 log10 IU/mL, respectively. b The mean reduction in serum HBV DNA levels from baseline to week 48 was similar in tenofovir and entecavir group (−5.22 vs. −5.01 log10 IU/mL, P = 0.559) by repeated measure analysis

Back to article page